Jurjen J Luykx

Summary

Affiliation: University Medical Center Utrecht
Country: The Netherlands

Publications

  1. doi request reprint Region and state specific glutamate downregulation in major depressive disorder: a meta-analysis of (1)H-MRS findings
    J J Luykx
    Department of Psychiatry, University Medical Center Utrecht, Utrecht, The Netherlands
    Neurosci Biobehav Rev 36:198-205. 2012
  2. doi request reprint Are migraineurs at increased risk of adverse drug responses? A meta-analytic comparison of topiramate-related adverse drug reactions in epilepsy and migraine
    J Luykx
    Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, University of California at Los Angeles, Los Angeles, California, USA
    Clin Pharmacol Ther 85:283-8. 2009
  3. doi request reprint The involvement of GSK3beta in bipolar disorder: integrating evidence from multiple types of genetic studies
    J J Luykx
    Rudolf Magnus Institute of Neuroscience, Department of Psychiatry, University Medical Center Utrecht, B01 206, P O Box 85500, 3508 GA Utrecht, The Netherlands
    Eur Neuropsychopharmacol 20:357-68. 2010
  4. doi request reprint Nervous system adverse responses to topiramate in the treatment of neuropsychiatric disorders
    Jurjen J Luykx
    University Medical Center Utrecht, Department of Psychiatry, p a Jurjen Luykx, PO Box 85500, 3508 GA Utrecht HP B01 206, The Netherlands
    Expert Opin Drug Saf 9:623-31. 2010

Detail Information

Publications4

  1. doi request reprint Region and state specific glutamate downregulation in major depressive disorder: a meta-analysis of (1)H-MRS findings
    J J Luykx
    Department of Psychiatry, University Medical Center Utrecht, Utrecht, The Netherlands
    Neurosci Biobehav Rev 36:198-205. 2012
    ..These results fit the central role of the ACC in depressive symptomatology and suggest that in MDD changes in glutamatergic neurotransmission are state-dependent...
  2. doi request reprint Are migraineurs at increased risk of adverse drug responses? A meta-analytic comparison of topiramate-related adverse drug reactions in epilepsy and migraine
    J Luykx
    Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, University of California at Los Angeles, Los Angeles, California, USA
    Clin Pharmacol Ther 85:283-8. 2009
    ..03-2.98) for 50 mg but no different for the other doses. We conclude that when treated with the same doses of topiramate, migraineurs show different ADRs than patients with epilepsy and are more likely to drop out because of ADRs...
  3. doi request reprint The involvement of GSK3beta in bipolar disorder: integrating evidence from multiple types of genetic studies
    J J Luykx
    Rudolf Magnus Institute of Neuroscience, Department of Psychiatry, University Medical Center Utrecht, B01 206, P O Box 85500, 3508 GA Utrecht, The Netherlands
    Eur Neuropsychopharmacol 20:357-68. 2010
    ..Future studies investigating the effects of GSK3beta manipulation in BD seem warranted...
  4. doi request reprint Nervous system adverse responses to topiramate in the treatment of neuropsychiatric disorders
    Jurjen J Luykx
    University Medical Center Utrecht, Department of Psychiatry, p a Jurjen Luykx, PO Box 85500, 3508 GA Utrecht HP B01 206, The Netherlands
    Expert Opin Drug Saf 9:623-31. 2010
    ..Studying ADR profiles across disorders is clinically relevant because treatment decision-making in neuropsychiatry is highly guided by ADR profiles...